SD HEALTHCARE

Beacon Discovery Expands, Partners with Escient Pharmaceuticals

San Diego-based Beacon Discovery has added square footage and employees following partnership deals.

Todd Nelson hired as CEO of SGI-DNA

San Diego’s SGI-DNA, a spinout of Synthetic Genomics, has named life sciences veteran Todd Nelson as CEO.

GreatCall Moves to New Office

Company expands but stays in Pacific Plaza

Tease photo

Co. Readies Finances For Commercialization

PHARMA: Heron’s Anesthetic Aims to Reduce Opioid Use

Heron Therapeutics is now turning its attention toward commercialization of its postoperative anesthetic, riding a regulatory environment that appears to be itching for opioid alternatives.

Tease photo

Adamis’ Stock Rises on Commercialization Deal

San Diego-based Adamis Pharmaceuticals, which makes an allergy syringe, has signed over commercial rights to a division of Novartis.

DJO Works Its Way Back to Better Health

DEVICES: Multipronged Plan Improves Earnings Trajectory

DJO Global CEO Brady Shirley likened the company’s business transformation plan to a knee surgery: short-term pain for long-term gain.

Tease photo

Biotech Acquisitions Have Their Own Trials

Mergers: Pharma Must Consider Many Factors in Buy

Earlier this month, an executive from New Jersey-based Celgene blamed Receptos, a San Diego firm that it bought, for a major regulatory setback.

Tease photo

Gossamer Licenses Compounds From Aerpio, Deal Worth up to $420M

San Diego-based Gossamer Bio entered into an agreement to develop and commercialize compounds from Cincinnati’s Aerpio Pharmaceuticals, in a deal worth as much as $420 million.

Salk Institute Associate Professor Wins Award, $250,000 Prize

An associate professor with Salk Institute was named one of three winners of the Blavatnik National Awards for Young Scientists, which comes with $250,000 for her pioneering bacteria research.

Kura Oncology Hires COO

John Farnam of Receptos has been named as COO of Kura Oncology. He will start in the newly created position July 1.

Calibr, AbbVie Announce Collaboration

Calibr, a nonprofit affiliated with Scripps Research, announced a collaboration with pharmaceutical AbbVie built on developing therapies, primarily for cancer, including solid tumors.

In a First, FDA Approves Cannabis-Based Drug

The U.S. Food and Drug Administration has approved a plant-derived cannabis medicine, benefitting Carlsbad’s Greenwich Biosciences, the U.S. subsidiary of United Kingdom-based GW Pharmaceuticals.

Some See Tandem’s Stock Price Continuing on Its Climb

BIOTECH: It’s Still Low For Medtech Peers; Co. Inks International Deals

This comeback story appears to have legs.

Tease photo

Trovagene CEO Resigns

William Welch has resigned as CEO and director of San Diego biotech Trovagene, citing personal reasons. The resignation is effective immediately.

FDA Approval for Tandem Diabetes Care's Automated Insulin Tech

Tandem Diabetes Care won U.S. Food and Drug Administration approval for an automated insulin technology designed to reduce the frequency and duration of low blood sugar events.